力竭运动及恢复期大鼠纹状体5-HT、DA及其代谢物浓度的动态变化研究

目的:观察一次性力竭运动过程及恢复期大鼠纹状体细胞外液中多巴胺(DA)和5-羟色胺(5-HT)及其代谢物浓度的动态变化规律。方法:采用活体微透析结合毛细管电泳-激光诱导技术,连续观察清醒大鼠在一次性力竭运动过程及恢复期纹状体细胞外液中酪氨酸(Tyr)、5-HT、5-羟吲哚乙酸(5-HIAA)、色氨酸(Trp)和DA浓度的动态变化。结果:大鼠纹状体细胞外液中Trp、5-HT、5-HIAA水平运动初期均未见显著变化(P>0.05),运动后期、力竭及恢复期均显著高于安静水平(P<0.05,P<0.01);DA、Tyr水平在运动后期、力竭及恢复期显著高于安静水平(P<0.05,P<0.01);DA/5-HT运动初期显著升高(P<0.05,P<0.01),运动后期出现下降趋势,力竭前15 min降至最低点,而恢复期略有回升,但运动后期、力竭及恢复期与安静状态相比均无显著差异。结论:力竭运动过程中大鼠纹状体细胞外液中DA和5-HT的动态变化具有阶段性特征,运动疲劳过程中状体内DA和5-HT两种神经递质的代谢水平均显著增强,而其中以5-HT的作用占优。     

一次性力竭运动致大鼠骨骼肌氧化应激的机制

目的:观察一次性力竭运动对大鼠骨骼肌氧化应激相关酶表达的影响。方法:雄性SD大鼠40只,分为4组(n=10),分别为对照组(C组)、力竭运动组(E组)、运动+PKC抑制剂组(EC组)、运动+NOX抑制剂组(EA组)。三组运动大鼠进行3 d的跑台适应性运动(5 m/min,1次/日,无坡度),然后休息1 d; EC组于运动前1 d和运动前1 h注射PKC抑制剂白屈菜红碱(5 mg/kg),EA组同期注射NADPH氧化酶抑制剂Apocynin(10 mg/kg),C组和E组注射同等剂量生理盐水;三组运动大鼠进行一次性跑台力竭运动,力竭后取大鼠的跖肌,DCF荧光探针检测活性氧(ROS),Western blot分析NOX2、NOX4、3-NT,免疫沉淀分析PKC、NOX2、NOX4。结果:与C组相比,E组的ROS水平、NOX2和NOX4蛋白表达、PKC-NOX2和PKC-NOX4复合物水平、3-NT生成均显著增加(P <0. 01,P <0.05),EC组、EA组ROS无显著差异(P>0.05),EC组NOX4蛋白表达显著增加(P<0.05);与E组相比,EC组和EA...     

大鼠游泳运动疲劳模型力竭标准的研究

目的:探讨不同力竭标准判断对负重大鼠游泳运动疲劳程度的影响.方法:成年雄性SD大鼠24只,随机分为对照组、运动组1、运动组2,每组8只,每天对负重大鼠进行游泳训练,运动组1以大鼠连续反复下沉,沉入水下三次,每次超过五秒为力竭标准,运动组2以沉入水下十秒钟,且游泳失去平衡为评判标准,对照组不参与游泳运动,试验期为十天,记录游泳时间,末了处死大鼠,取血液、肝、骨骼肌,同时检测相应组织超氧化物歧化酶活性,乳酸、丙二醛的含量.最后进行统计比较和分析.结果:运动组1随着游泳天数的增加,游泳时间呈逐渐延长趋势,运动组2游泳随着游泳天数的增加,游泳时间呈缩短趋势.运动组1和对照组相比较,血清、骨骼肌丙二醛和乳酸明显高(P<0.05),肝变化不明显(P>0.05);超氧化物歧化酶的活性均明显降低(P<0.05).运动组2和对照组、运动组1相比较,血清、骨骼肌丙二醛和乳酸明显高(P<0.05),肝变化不明显(P>0.05);超氧化物歧化酶的活性均明显降低(P<0.05).结论:采用运动组2疲劳力竭判断标准是可靠的,可用于运动性疲劳机制的试验性研究.     

跑台运动对攻击行为大鼠内侧下丘脑和中脑导水管周围灰质5-HT1A受体、5-HT2A受体蛋白表达的影响

目的:探讨跑台运动对攻击行为大鼠内侧下丘脑(MH)和中脑导水管周围灰质(PAG)5-HT1A受体、5-HT2A受体蛋白表达的影响,为研究运动对攻击行为改善的神经生物学机制提供实验基础.方法:3月龄雄性SD大鼠40只,体重160～180 g,随机分为4组:安静组(A)、攻击模型组(G)、攻击跑台组(GP)、入侵组(R)....     

力竭运动后不同时相大鼠心电图、心功能变化及Nrf2的作用

目的：研究大鼠力竭运动及运动结束后心电图、心功能的动态变化规律及转录因子E2相关因子（Nrf2）相关的氧化应激变化,为运动性心脏损伤防治提供依据。方法：SD大鼠随机分为5组（n=6）：对照组（Con）组、力竭组（EE）、力竭恢复6 h,12 h,24 h组（EER6、EER12、EER24组）。急性力竭游泳建立损伤模型。分别对各组动物进行心电图描记,压力容积导管检测心功能改变,ELISA法观测血清ROS,Nrf2,GPX及CAT变化。结果：① EE组心率（HR）,收缩末期压力（Pes）,发展压,动脉弹性,压力上升,下降最大速率（dP/dt_max、-dP/dt_min）降至最低。舒张末期压力容积、收缩末期容积、搏出量、Tau值增大。EER6、EER12、EER24组HR、Pes、dP/dt_max、-dP/dt_min与EE组相比均差异显著。②EE组、EER6、EER12、EER24组与Con组相比心率加快,QT间期延长,P波R波ST段数值增高,但恢复各组与EE组相比无统计学意义。③EE组大鼠血清ROS、Nrf2含量升高,GPX含量降低,CAT在EER6组降至最低。④血清Nrf2水平与ROS,-dP/dt_min呈正相关,与HR、Ea呈负相关。血清ROS水平与EF,-dP/dt_min呈正相关,与HR、Ea、dP/dt_max呈负相关。结论：力竭运动后心脏生物电改变,舒缩功能均受损,以舒张功能减退突出,随力竭恢复时间延长,心脏舒缩功能逐步恢复,这与Nrf2调节GPX,CAT降低氧化应激有关。     

大鼠力竭运动中丘脑底核和皮层神经元电活动的变化

目的：探讨力竭过程中丘脑底核（SIN）对皮层兴奋性的调控作用。方法：采用皮层脑电（ECoG）及局部场电（LFPs）同步记录技术,对一次性力竭运动过程中大鼠SIN、皮层神经元电活动变化规律进行同步、动态观察。结果：运动开始阶段大鼠能够自主跟随跑台进行运动,运动持续约45min时（45±11．5min）,自我驱动下的运动能力明显降低;此时STN兴奋性显著增加（P〈0．01）,皮层兴奋性显著下降（P〈0．01）。如果给予大鼠一定的外部刺激后仍可继续运动一段时间直至力竭;力竭即刻皮层兴奋性降到最低值（P〈0．01）,而SIN兴奋性变化不显著（P〉0．05）。结论：大鼠在力竭运动过程中,皮层运动区神经元电活动随着运动疲劳的发生呈现广泛的抑制现象,而SIN神经元电活动在疲劳初期则明显增强,SIN通过负诱导作用参与了运动性中枢疲劳的调控,且STN神经元兴奋性增强可能是皮层实现保护性抑制机制的重要途径之一。     

急性力竭运动对大鼠胃肠传输速率及回肠肌间神经丛氮能神经的影响

目的：研究力竭运动对大鼠胃肠动力的影响及其肠神经机制。方法：24只大鼠随机分成对照组和急性力竭运动组,建立力竭运动大鼠模型,测定胃肠传输速率,用酶组织化学方法和计算机图像分析技术对两组大鼠回肠肌间神经丛内氮能神经元的数目和一氧化氮合酶（NOS）的表达进行测定。结果：急性力竭运动组大鼠胃肠传输速率明显延迟,回肠肌间神经丛内氮能神经元的数目明显增多和NOS的表达显著增强（P〈0．05和P〈0．01）。结论：大鼠力竭运动后小肠肌问神经丛内氮能神经元的数目增多和NOS的表达增强可能是导致胃肠传输速率延迟的重要原因之一。     

力竭性运动对大鼠肝脏线粒体氧化磷酸化偶联的影晌

本文以ＳＤ大鼠三级递增负荷力竭性跑台运动为疲劳模型,分别测定了运动后即刻肝脏线粒体：１．呼吸链复合体Ⅰ＋Ⅲ和Ⅱ＋Ⅲ电子传递与质子泵出比值（Ｈ＋／２ｅ）;２．以苹果酸＋谷氨酸（Ｍ＋Ｇ）和琥珀酸（Ｓ）为底物的呼吸控制：态３呼吸速率（Ｒ３）、态４呼吸速率（Ｒ４）、呼吸控制率（ＲＣＲ）和磷／氧比（Ｐ／Ｏ）。结果表明：两种呼吸底物启动的线粒体态４呼吸速率分别升高６４．４６和２３．５４％（Ｐ＜０．００１和Ｐ＜０．０５）;呼吸链复合体Ⅰ＋Ⅲ和Ⅱ＋Ⅲ的总Ｈ＋／２ｅ分别降低１８．６３和１５．８９％（均Ｐ＜０．０１）。两种呼吸底物的ＲＣＲ和Ｐ／Ｏ呈显著降低（均Ｐ＜０．０５）;Ｍ＋Ｇ为呼吸底物的态３呼吸速率也呈显著增加（Ｐ＜０．０１）,Ｓ为呼吸底物的态３呼吸速率略有增高（Ｐ＞０．０５）。提示,线粒体质子漏增加,呼吸链电子传递与质子泵出偶联程度下降,氧化磷酸化脱偶联导致无效氧耗增多,可能是运动性疲劳状态下线粒体氧利用率下降的重要机制。     

牛磺酸对运动大鼠甲状腺激素及心肌第二信使的影响

目的：探讨牛磺酸对力竭运动后大鼠心肌损伤的保护作用。方法：以大鼠力竭运动为模型,研究牛磺酸对血清和心肌中四碘甲腺原氨酸（T4）和三碘甲腺原氨酸（T3）,心肌T45’－脱单碘酸（T45’－DI）活性、环磷酸腺苷（cAMP）水平的影响。结果：力竭运动可造成血清和心肌中T3水平、心肌中T45’－DI活力和cAMP含量显著升高（P＜0．01）,T4水平无显著性改变;而补充牛磺酸可显著抑制力竭运动后大鼠血清和心肌中T3水平的升高,抑制心肌中T45’－DI活力和cAMP含量的显著增加。结论：牛磺酸对大鼠力竭运动后心肌损伤具有一定的保护作用。     

短期和长期运动预适应对力竭大鼠心肌损伤的保护作用

目的：研究短期和长期运动预适应对心肌细胞凋亡保护中发挥的作用及机制。方法：48只雄性SD大鼠随机分为对照组（C）、力竭组（E）、短期运动预适应组（S-EP）、长期运动预适应组（L-EP）。短期和长期运动预适应分别进行3 d和3周的反复间歇游泳训练方案。光镜下观察心肌细胞的结构改变;ELISA方法检测血清中缺血修饰白蛋白（IMA）、磷酸肌酸同工酶（CK-MB）含量;实时荧光定量PCR和Western blot方法检测心肌组织中TNF-α、Caspase-8、Caspase-3基因和蛋白表达;采用DNA原位末端标记（TUNEL）法观察心肌细胞的凋亡情况。结果：与C组相比,E组心肌细胞损伤严重,血清IMA、CK-MB含量及心肌组织中TNF-α、Caspase-8、Caspase-3 mRNA和蛋白表达升高（P<0.05）;与E组相比,S-EP组血清CK-MB及心肌TNF-α、Caspase-8mRNA明显降低（P<0.05）,而蛋白表达无统计学差异,血清IMA及Caspase-3 mRNA和蛋白均下降不明显,无统计学意义（P>0.05）,L-EP组血清IMA、CK-MB含量及心肌TNF-α、Caspase-8、Caspase-3 mRNA及蛋白明显降低,有统计学意义（P<0.05）;与S-EP组相比,L-EP组血清IMA、CK-MB含量及TNF-α、Caspase-8、Caspase-3 mRNA和蛋白明显下降,有统计学意义（P<0.05）。E组心肌细胞凋亡明显,S-EP组和L-EP组均能抑制凋亡,且L-EP组与S-EP组相比心肌凋亡明显减少。结论：短期和长期运动预适应均可减轻力竭后的心肌损伤,但短期运动预适应并未改变Caspase蛋白酶的表达,长期运动预适应明显抑制Caspase-8、3 mRNA表达,减少蛋白合成,从而发挥心肌保护效应,故长期运动预适应在抑制心肌细胞凋亡方面较短期运动预适应更强。     

Activation of 5-HT(1A) but not 5-HT(1B) receptors attenuates an increase in extracellular dopamine derived from exogenously administered L-DOPA in the striatum with nigrostriatal denervation

In order to determine whether L-DOPA-derived extracellular dopamine (DA) in the striatum with dopaminergic denervation is affected by activation of serotonin autoreceptors (5-HT(1A) and 5-HT(1B) receptors), we applied in vivo brain microdialysis technique to 6-hydroxydopamine-lesioned rats and examined the effects of the selective 5-HT(1A) receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and the selective 5-HT(1B) receptor agonist CGS-12066 A on L-DOPA-derived extracellular DA levels. Single L-DOPA injection (50 mg/kg i.p.) caused a rapid increase and a following decrease of extracellular DA, with a peak value at 100 min after L-DOPA injection. Pretreatment with both 0.3 mg/kg and 1 mg/kg 8-OH-DPAT (i.p.) significantly attenuated an increase in L-DOPA-derived extracellular DA and the times of peak DA levels were prolonged to 150 min and 225 min after L-DOPA injection, respectively. These 8-OH-DPAT-induced changes in L-DOPA-derived extracellular DA were antagonized by further pretreatment with WAY-100635, a selective 5-HT(1A) antagonist. In contrast, intrastriatal perfusion with the 5-HT(1B) agonist CGS-12066 A (10 nM and 100 nM) did not induce any changes in L-DOPA-derived extracellular DA. Thus, stimulation of 5-HT(1A) but not 5-HT(1B) receptors attenuated an increase in extracellular DA derived from exogenous L-DOPA. These results support the hypothesis that serotonergic neurons are primarily responsible for the storage and release of DA derived from exogenous L-DOPA in the absence of dopaminergic neurons.     

5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release

Atypical antipsychotic drugs (APDs), all of which are relatively more potent as serotonin (5-HT)(2A) than dopamine D(2) antagonists, may improve negative symptoms and cognitive dysfunction in schizophrenia, in part, via increasing cortical dopamine release. 5-HT(1A) agonism has been also suggested to contribute to the ability to increase cortical dopamine release. The present study tested the hypothesis that clozapine, olanzapine, risperidone, and perhaps other atypical APDs, increase dopamine release in rat medial prefrontal cortex (mPFC) via 5-HT(1A) receptor activation, as a result of the blockade of 5-HT(2A) and D(2) receptors. M100907 (0.1 mg/kg), a 5-HT(2A) antagonist, significantly increased the ability of both S:(-)-sulpiride (10 mg/kg), a D(2) antagonist devoid of 5-HT(1A) affinity, and R:(+)-8-OH-DPAT (0.05 mg/kg), a 5-HT(1A) agonist, to increase mPFC dopamine release. These effects of M100907 were abolished by WAY100635 (0.05 mg/kg), a 5-HT(1A) antagonist, which by itself has no effect on mPFC dopamine release. WAY100635 (0.2 mg/kg) also reversed the ability of clozapine (20 mg/kg), olanzapine (1 mg/kg), risperidone (1 mg/kg), and the R:(+)-8-OH-DPAT (0.2 mg/kg) to increase mPFC dopamine release. Clozapine is a direct acting 5-HT(1A) partial agonist, whereas olanzapine and risperidone are not. These results suggest that the atypical APDs via 5-HT(2A) and D(2) receptor blockade, regardless of intrinsic 5-HT(1A) affinity, may promote the ability of 5-HT(1A) receptor stimulation to increase mPFC DA release, and provide additional evidence that coadministration of 5-HT(2A) antagonists and typical APDs, which are D(2) antagonists, may facilitate 5-HT(1A) agonist activity.     

猫下丘中央核5-HT、P物质和星形胶质细胞年龄相关变化

目的比较研究青年猫与老年猫下丘中央核(CIC)5-羟色氨(5-HT)、P物质(SP)能神经元及星形胶质细胞年龄性变化,探索老年个体听力下降的神经机制。方法 Nissl染色显示下丘神经元,免疫组织化学ABC法显示5-HT、SP和胶质纤维酸性蛋白(GFAP)免疫反应(immunoreactive,IR)细胞。光镜下观察、拍照,对神经元和5-HT、SP及GFAP免疫反应细胞分别计数并换算成密度,测量其IR细胞直径取平均值,以及它们的阳性反应平均灰度值。结果 5-HT-IR、SP-IR和GFAP-IR细胞、阳性纤维及其终末在青年猫及老年猫下丘中央核均有分布。与青年猫相比,老年猫下丘中央核5-HT密度均显著下降(P<0.01),胞体直径明显减小(P<0.01),阳性反应明显减弱(阳性反应强度与灰度值呈负相关),SP-IR神经元和星形胶质细胞密度却显著增大,阳性反应显著增强。结论在衰老过程中猫下丘神经元尤其是5-HT能神经元有显著丢失现象,提示5-HT能神经元显著减少导致下丘听觉信息传递功能减弱,可能引起老年个体听觉功能衰退的重要原因;SP能神经元和星形胶质细胞密度显著增大,可能起到延缓衰老的作用。     

Regional changes in density of serotonin transporter in the brain of 5-HT1A and 5-HT1B knockout mice, and of serotonin innervation in the 5-HT1B knockout

5-HT1A knockout (KO) mice display an anxious-like phenotype, whereas 5-HT1B KOs are over-aggressive. To identify serotoninergic correlates of these altered behaviors, autoradiographic measurements of 5-HT1A and 5-HT1B serotonin (5-HT) receptors and transporter (5-HTT) were obtained using the radioligands [3H]8-OH-DPAT, [125I]cyanopindolol and [3H]citalopram, respectively. By comparison to wild-type, density of 5-HT1B receptors was unchanged throughout brain in 5-HT1A KOs, and that of 5-HT1A receptors in 5-HT1B KOs. In contrast, decreases in density of 5-HTT binding were measured in several brain regions of both genotypes. Moreover, 5-HTT binding density was significantly increased in the amygdalo-hippocampal nucleus and ventral hippocampus of the 5-HT1B KOs. Measurements of 5-HT axon length and number of axon varicosities by quantitative 5-HT immunocytochemistry revealed proportional increases in the density of 5-HT innervation in these two regions of 5-HT1B KOs, whereas none of the decreases in 5-HTT binding sites were associated with any such changes. Several conclusions could be drawn from these results: (i) 5-HT1B receptors do not adapt in 5-HT1A KOs, nor do 5-HT1A receptors in 5-HT1B KOs. (ii) 5-HTT is down-regulated in several brain regions of 5-HT1A and 5-HT1B KO mice. (iii) This down-regulation could contribute to the anxious-like phenotype of the 5-HT1A KOs, by reducing 5-HT clearance in several territories of 5-HT innervation. (iv) The 5-HT hyperinnervation in the amygdalo-hippocampal nucleus and ventral hippocampus of 5-HT1B KOs could play a role in their increased aggressiveness, and might also explain their better performance in some cognitive tests. (v) These increases in density of 5-HT innervation provide the first evidence for a negative control of 5-HT neuron growth mediated by 5-HT1B receptors.     

Selective reduction by isolation rearing of 5-HT1A receptor-mediated dopamine release in vivo in the frontal cortex of mice

Serotonin (5-HT)1A receptors modulate in vivo release of brain monoaminergic neurotransmitters which may be involved in isolation-induced aggressive behavior. The present study examined the effect of isolation rearing on the 5-HT1A receptor-mediated modulation of dopamine (DA), 5-HT and noradrenaline (NA) release in the frontal cortex of mice. The selective 5-HT1A receptor agonist (S)-5-[-[(1,4-benzodioxan-2-ylmethyl)amino]propoxy]-1,3-benzodioxole HCl (MKC-242) increased the release of DA and NA and decreased the release of 5-HT in the frontal cortex of mice. The effect of MKC-242 on DA release was significantly less in isolation-reared mice than in group-reared mice, while effects of the drug on NA and 5-HT release did not differ between both groups. The effect of the other 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin on cortical DA release was also less in isolation-reared mice than in group-reared mice, and that of the drug on cortical 5-HT release did not differ between both groups. In contrast to MKC-242-induced DA release, amphetamine-induced increase in cortical DA release in vivo was greater in isolation-reared mice. The present findings suggest that isolation rearing enhances the activity of cortical dopaminergic neurons and reduces selectively the 5-HT1A receptor-mediated release of DA in the cortex.     

Enhanced activation of Akt and extracellular-regulated kinase pathways by simultaneous occupancy of Gq-coupled 5-HT2A receptors and Gs-coupled 5-HT7A receptors in PC12 cells

The most commonly prescribed antidepressants, the serotonin (5-HT) selective reuptake inhibitors, increase 5-HT without targeting specific receptors. Yet, little is known about the interaction of multiple receptor subtypes expressed by individual neurons. Specifically, the effect of increases in cAMP induced by Gs-coupled 5-HT receptor subtypes on the signaling pathways modulated by other receptor subtypes has not been studied. We have, therefore, examined the activation of the extracellular-regulated kinase (ERK) and Akt pathways by Gs-coupled 5-HT7A receptors and Gq-coupled 5-HT2A receptors, which are co-expressed in discrete brain regions. Agonists for both receptors were found to activate ERK and Akt in transfected PC12 cells. 5-HT2A receptor-mediated activation of the two pathways was found to be Ca2+-dependent. In contrast, 5-HT7A receptor-mediated activation of Akt required increases in both [cAMP] and intracellular [Ca2+], while activation of ERK was inhibited by Ca2+. The activation of ERK and Akt stimulated by simultaneous treatment of cells with 5-HT2A and 5-HT7A receptor agonists was found to be at least additive. Cell-permeable cAMP analogs mimicked 5-HT7A receptor agonists in enhancing 5-HT2A receptor-mediated activation of ERK and Akt. A role was identified for the cAMP-guanine exchange factor, Epac, in this augmentation of ERK, but not Akt, activation. Our finding of enhanced activation of neuroprotective Akt and ERK pathways by simultaneous occupancy of 5-HT2A and 5-HT7A receptors may also be relevant to the interaction of other neuronally expressed Gq- and Gs-coupled receptors.     

Acquisition of and withdrawal from cocaine self-administration regulates 5-HT1B mRNA expression in rat striatum

This study investigated how different stages of cocaine self-administration in rats affect the expression of two serotonin receptors in dorsal and ventral striatum, the 5-HT_1B and 5-HT₆ subtypes, which have both been implicated in mediating some aspects of cocaine-related behaviors. In the first experiment, rats were trained to work for saccharin (oral) or cocaine (i.v.) reinforcers. We found that continuous access to cocaine for 23 days did not change the level of 5-HT_1B mRNA expression compared to control animals receiving saccharin. However, a single cocaine session, given either by self-administration or non-contingently, increased 5-HT_1B mRNA in dorsal striatum, whereas forced abstinence for two weeks after cocaine reduced 5-HT_1B mRNA expression in the same subregion. 5-HT₆ mRNA was not changed by any of these treatments. A follow-up experiment investigated the effects of limited versus extended access to cocaine as well as forced abstinence, and we found that 14 days of forced abstinence significantly reduced 5-HT_1B mRNA throughout the dorsal and ventral striatum compared to no withdrawal. These results suggest that the influence of 5-HT_1B receptors in striatal projection neurons may be increased during cocaine acquisition and reduced after forced abstinence and may therefore be targets for pharmacological intervention in addiction.     

5-HT2和5-HT3受体在外周初级感觉神经末梢痛反应和痛调制中的相互作用

目的：探讨5-HT2和5-HT3受体亚型在5-HT引起外周痛反应和痛调制中的相互作用及其机制;方法：在大鼠三又神经节神经元标本上应用全细胞膜片钳技术记录5-羟色胺激活电流（15_HT）,并结合痛行为实验进行观察。结果：在大多数受检细胞（54／88,61．4％）特别是中、小型细胞外加5-HT可引起一快去敏感的内向电流,此内向电流能被5-HT,受体特异性激动剂2-甲基-5-羟色胺所模拟,被5-HT3受体拮抗剂ICS250-930可逆性阻断,而5-HT2受体激动剂α-甲基-5-羟色胺则有明显增强15-HT的作用,5-HT1受体激动剂R-（＋）-UH301无明显反应。在进一步的整体清醒动物的行为学试验中我们观察到,大鼠后肢掌底皮下注射5-HT（10-5,10-4和10-3mol／L）引起浓度依赖性的痛行为反应,而用5-HT2和5-HT3受体特异性拮抗剂Cyproheptadine和ICS250-930分别阻断相应受体亚型后,5-HT引起的痛行为反应的强度序列为：5-HT〉5-HT＋ICS〉5-HT＋Cyp。结论：本文结果提示：5-HT所引起的痛反应中,在初级感觉神经元水平5-HT3受体可能仅起着启始作用,而5-HT,受体则在伤害性信息的维持和调制过程中发挥更大的作用。     

Dopamine receptor regulation of Ca2+ levels in individual isolated nerve terminals from rat striatum: comparison of presynaptic D1-like and D2-like receptors

We have directly observed the effects of activating presynaptic D1-like and D2-like dopamine receptors on Ca2+ levels in isolated nerve terminals (synaptosomes) from rat striatum. R-(+)-SKF81297, a selective D1-like receptor agonist, and (-)-quinpirole, a selective D2-like receptor agonist, induced increases in Ca2+ levels in different subsets of individual striatal synaptosomes. The SKF81297- and quinpirole-induced effects were blocked by R-(+)-SCH23390, a D1-like receptor antagonist, and (-)-sulpiride, a D2-like receptor antagonist, respectively. SKF81297- or quinpirole-induced Ca2+ increases were inhibited following blockade of voltage-gated calcium channels or sodium channels. In a larger subset of synaptosomes, quinpirole decreased baseline Ca2+. Quinpirole also inhibited veratridine-induced increases in intrasynaptosomal Ca2+ level. Immunostaining confirmed the presynaptic expression of D1, D5, D2 and D3 receptors, but not D4 receptors. The array of neurotransmitter phenotypes of the striatal nerve endings expressing D1, D5, D2 or D3 varied for each receptor subtype. These results suggest that presynaptic D1-like and D2-like receptors induce increases in Ca2+ levels in different subsets of nerve terminals via Na+ channel-mediated membrane depolarization, which, in turn, induces the opening of voltage-gated calcium channels. D2-like receptors also reduce nerve terminal Ca2+ in a different but larger subset of synaptosomes, consistent with the predominant presynaptic action of dopamine in the striatum being inhibitory.